Third Covid jab likely for highly vulnerable patients
Recently USFDA gave its nod for the use of Pfizer-BioNTech and Moderna Covid vaccines as additional dose on certain immunocompromised individuals
Hyderabad: A third dose of Covid vaccine to further strengthen immunity from Covid-19 among the highly vulnerable population in Telangana and across the country could soon be a reality.
Recently, the US Food and Drug Administration (USFDA) gave its nod for the use of Pfizer-BioNTech and Moderna Covid vaccines as additional dose on certain immunocompromised individuals.
“Third doses are not currently recommended in many countries. But it should be considered. Different vaccines need to be evaluated in sets of patients to see which vaccine (or combinations) offer the most benefit to these groups of vulnerable people. However, not boosters at this time,” renowned virologist and member of the Covid Working Group, MOHFW, New Delhi, Dr Gagandeep Kang said on Tuesday.
The highly regarded virologist took to Twitter to clarify more on the issue of Covid booster vaccines. While maintaining that there was no India-specific data on the need for booster doses, Dr Kang said that a third Covid shot for vulnerable patients should be considered. “Who needs the booster dose and when? At the moment, we do not know. The FDA recommendation is not for boosters as much as recognition that people with poor immune responses should get a third dose as part of their primary series of immunizations,” Dr Kang said.
The list of vulnerable patient population includes solid organ transplant recipients, those getting active treatment for solid tumours and haematologic malignancies, those with CAR T cell therapy or within two years of stem cell transplant, moderate or severe primary immunodeficiency (e.g., DiGeorge, Wiskott-Aldrich syndromes), advanced or untreated HIV infection or active treatment, with high-dose corticosteroids,” she said.
Dr Kang also highlighted the need for India specific data, which points towards the need to roll out booster doses. “Yes, some countries that have used inactivated, vectored vaccines or mRNA vaccines have begun to offer booster doses to selected populations, like the elderly. In India (and elsewhere), we do not have any data showing that anyone who has received two doses of vaccine needs booster vaccines at this time,” Dr Kang said.
“It sounds obvious that more antibodies are better, but we really don’t know whether people who push up antibodies with additional doses will be better protected than with the level they initially made. Or that when antibodies wane, we need to boost to maintain above some level,” Dr Kang added.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .
